Artiva Biotherapeutics, Inc. Share Price
NASDAQ: ARTV | Micro CapArtiva Biotherapeutics, Inc. Stock Performance
Artiva Biotherapeutics, Inc. Share Price Today
As of 29 October 2026, Artiva Biotherapeutics, Inc.'s share price is $4.25. The stock opened at $4.23, compared to its previous close of $4.25. During today's trading session, Artiva Biotherapeutics, Inc.'s share price traded between $4.16 and $4.27, with an average price of $4.21. Over the past 52 weeks, the stock has recorded a high of $14.47 and a low of $3.01. In terms of performance, Artiva Biotherapeutics, Inc.'s share price has declined by 58.62% over the last six months and is up 0.71% on a year-on-year basis.
Artiva Biotherapeutics, Inc. Share Price Chart
Artiva Biotherapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Artiva Biotherapeutics, Inc. Annual Profit & Loss
All figures in USD
About Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).
Artiva Biotherapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $6.92 | $4.25 | -40.30% |
Sep 2026 | $11.06 | $7.11 | -40.50% |
Aug 2026 | $10.08 | $11.95 | +18.61% |
Jul 2026 | $9.75 | $10.07 | +3.76% |
Jun 2026 | $7.68 | $9.71 | +22.76% |
May 2026 | $9.90 | $7.91 | -22.98% |
Apr 2026 | $6.35 | $10.27 | +59.10% |
Mar 2026 | $5.54 | $6.46 | +8.31% |
Feb 2026 | $3.99 | $5.96 | +52.43% |
Jan 2026 | $4.17 | $3.91 | -8.64% |
Dec 2025 | $3.58 | $4.28 | +16.94% |
Nov 2025 | $4.18 | $3.66 | -13.27% |